{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:39:03Z","timestamp":1789141143349,"version":"build-2803163510"},"reference-count":121,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>Since the introduction of cyclosporin A (CsA) in the early 1980s, the use of immunosuppressants has markedly increased. Already established drugs have proved effective in the treatment of a wide range of diseases outside transplantation medicine and new immunosuppressants have been developed for more specific indications such as psoriasis and atopic dermatitis. Patients in transplantation medicine as well as in dermatology have benefited significantly from systemic and topical application of both new and established drugs. But are these drugs without risks? Cancer\u2010protecting effects have been reported for some of the available immunosuppressants. Conversely, other publications and the issue of a black box warning by the US Food and Drug Administration have increased concerns about cancer\u2010promoting effects. Knowledge of the specific effects as well as adverse effects is paramount to ensure an application that is safe and beneficial for the patient. Here we review the mechanisms of action and therapeutic potential, and critically review recent literature with respect to possible carcinogenic side effects of systemic and topical CsA, tacrolimus, pimecrolimus and rapamycin.<\/jats:p>","DOI":"10.1111\/j.1600-0625.2007.00555.x","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T06:07:23Z","timestamp":1177567643000},"page":"385-393","source":"Crossref","is-referenced-by-count":53,"title":["Calcineurin inhibitors and rapamycin: cancer protection or promotion?"],"prefix":"10.1111","volume":"16","author":[{"given":"Maren","family":"Weischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6238408"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/341758a0"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4160(02)00051-9"},{"key":"e_1_2_7_5_2","first-page":"618","article-title":"The macrolide immunosuppressants in dermatology: mechanisms of action","volume":"12","author":"Marsland A M","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.38.22602"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.11205"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/356801a0"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1702904"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90111-J"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01709.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70163-X"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.116865"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb17139.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204091"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.483"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/369756a0"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90570-3"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12574"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.2.815"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/377441a0"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.15.5575-5584.2002"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90643-Q"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.36.21176"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/377358a0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11477"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.23.14424"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90257-7"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/372570a0"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.9.4076"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00398.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90402-2"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.174"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371737"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.suppl_3.III-222"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92780-8"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2002.00765.x"},{"key":"e_1_2_7_38_2","unstructured":"http:\/\/www.fda.gov\/cder\/foi\/label\/2004\/21302s005lbl.pdf 2002(Internet Communication)."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04602.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2000.160601.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30148.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602162"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.6.4336"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91618-0"},{"key":"e_1_2_7_45_2","first-page":"51","article-title":"Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed","volume":"3","author":"Stewart T","year":"1997","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207778"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-002-0239-4"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509054764"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050274"},{"key":"e_1_2_7_50_2","first-page":"237","article-title":"Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia","volume":"228","author":"Larsson R","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104443200"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.2152\/jmi.51.63"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.1.67"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200205270-00008"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171076798"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171060098"},{"key":"e_1_2_7_57_2","first-page":"3895","article-title":"Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells","volume":"56","author":"Seufferlein T","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200405150-00002"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2004.00026.x"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2004.00188.x"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3540"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1362"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0189"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200301150-00025"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199508000-00010"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02574501"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.28645"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.29350"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199603150-00008"},{"key":"e_1_2_7_70_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-0012.1994.tb00383.x","article-title":"De novo cancer in cyclosporine\u2010treated and non\u2010cyclosporine\u2010treated adult primary renal allograft recipients","volume":"8","author":"Gruber S A","year":"1994","journal-title":"Clin Transplant"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)80084-4"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00120-4"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(01)00674-1"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2004.03.030"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe058018"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2001.6233"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199902270-00021"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000081399.75231.3B"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i10.1420"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050373"},{"key":"e_1_2_7_81_2","unstructured":"http:\/\/www.fda.gov\/cder\/drug\/InfoSheets\/HCP\/elidelHCP.htm 2005(Internet Communication)."},{"key":"e_1_2_7_82_2","unstructured":"http:\/\/www.fda.gov\/cder\/drug\/advisory\/elidel_protopic.htm 2006(Internet Communication)."},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2006.00413.x"},{"key":"e_1_2_7_84_2","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","author":"Arellano F M","year":"2006","journal-title":"J Invest Dermatol"},{"key":"e_1_2_7_85_2","unstructured":"http:\/\/www.emea.eu.int 2006(Internet Communication)."},{"key":"e_1_2_7_86_2","first-page":"61","article-title":"Cyclosporin A therapy for steroid\u2010dependent Henoch\u2010Schonlein purpura","volume":"36","author":"Huang D C","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(03)00008-0"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000055345"},{"key":"e_1_2_7_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(02)00655-6"},{"key":"e_1_2_7_90_2","first-page":"91","article-title":"Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis","volume":"50","author":"Okamura S","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.4.291"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050324"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2002.00387.x"},{"key":"e_1_2_7_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(97)80019-3"},{"key":"e_1_2_7_95_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2003.02105.x"},{"key":"e_1_2_7_96_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.105528"},{"key":"e_1_2_7_97_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068469"},{"key":"e_1_2_7_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.03.008"},{"key":"e_1_2_7_99_2","first-page":"423","article-title":"Recurrent corneal ulcer in a patient with Crohn's disease associated with epidermolysis bullosa acquisita","volume":"220","author":"Spraul C W","year":"2003","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"e_1_2_7_100_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05260.x"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033455035"},{"key":"e_1_2_7_102_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.5.581"},{"key":"e_1_2_7_103_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.169"},{"key":"e_1_2_7_104_2","first-page":"331","article-title":"Potential future dermatological indications for tacrolimus ointment","volume":"13","author":"Ruzicka T","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_7_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00002176"},{"key":"e_1_2_7_106_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.9.1202"},{"key":"e_1_2_7_107_2","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.2003.64.4.1779"},{"key":"e_1_2_7_108_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460508.x"},{"key":"e_1_2_7_109_2","first-page":"207","article-title":"Pimecrolimus: a new treatment for seborrheic dermatitis","volume":"70","author":"Crutchfield C E","year":"2002","journal-title":"Cutis"},{"key":"e_1_2_7_110_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D31XH7Z688","article-title":"Treatment of cutaneous lupus with Elidel","volume":"8","author":"Zabawski E","year":"2002","journal-title":"Dermatol Online J"},{"key":"e_1_2_7_111_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02554.x"},{"key":"e_1_2_7_112_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065863"},{"key":"e_1_2_7_113_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.1.e2"},{"key":"e_1_2_7_114_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04076.x"},{"key":"e_1_2_7_115_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04134.x"},{"key":"e_1_2_7_116_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000070421.38604.2B"},{"key":"e_1_2_7_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3162-3170.2001"},{"key":"e_1_2_7_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04376.x"},{"key":"e_1_2_7_119_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.7.s3.3.x"},{"key":"e_1_2_7_120_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200112270-00010"},{"key":"e_1_2_7_121_2","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein\u2013Barr virus B\u2010cell lymphomas","volume":"63","author":"Nepomuceno R R","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_7_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06438.x"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.2007.00555.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.2007.00555.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T22:26:45Z","timestamp":1736980005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.2007.00555.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1600-0625.2007.00555.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.2007.00555.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]}}}